The UK Department of Health has initiated a public consultation on a proposal to ban the prescription of soft gelatin gel-filled temazepam capsules under the National Health Service. The move has been made in the face of the widespread misuse of the capsules by injecting drug users. Comments on the proposal should be sent to the DoH by September 8.
John Bowis, parliamentary secretary at the Department of Health, said "the scale of the misuse of temazepam requires action," adding that "we are therefore proposing to take this action to reduce the availability of this form of the drug on the grounds of public health and safety."
Mr Bowis also noted that a ban on gel-filled temazepam capsules would only be part of the proposal. Other measures could include increasing safe custody controls on all formulations of temazepam in manufacturers' premises and warehouses, but the tablet and elixir formulations would remain available on NHS prescription in order to meet clinical need.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze